Skip to main navigation
Skip to search
Skip to main content
University of Kentucky Home
LOGIN & Help
Home
Research units
Researchers
Projects & Grants
Research Output
Facilities & Equipment
Honors & Awards
Activities
Search by expertise, name or affiliation
EFC16034: A Phase 3, randomized, double-blind efficacy and safety study comparing SAR442168 to teriflunomide (Aubagio) in participants with relapsing forms of multiple sclerosis (GEMINI 2)
Avasarala, Jagannadha
(PI)
Chalkley, Joshua
(CoI)
Neurology
Overview
Grants and Contracts Details
Status
Finished
Effective start/end date
8/20/20
→
1/12/24
Funding
Sanofi Aventis US Inc:
$13,631.00
View all
View less